Denton, C P <br/><br/>
Long-term effects of bosentan on quality of life, survival, safety and tolerability in pulmonary arterial hypertension related to connective tissue diseases.  [electronic resource] 

 -  Annals of the rheumatic diseases  Sep 2008 
 - 1222-8 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1468-2060 
<br/><br/><label>Standard No.: </label>10.1136/ard.2007.079921  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antihypertensive Agents--adverse effects<br/>Bosentan<br/>Connective Tissue Diseases--complications<br/>Drug Administration Schedule<br/>Drug Therapy, Combination<br/>Epidemiologic Methods<br/>Female<br/>Glucocorticoids--therapeutic use<br/>Humans<br/>Hypertension, Pulmonary--drug therapy<br/>Male<br/>Middle Aged<br/>Quality of Life<br/>Severity of Illness Index<br/>Sulfonamides--adverse effects<br/>Treatment Outcome